AIM
ORGO icon

Assured Investment Management’s Organogenesis Holdings ORGO Stock Holding History

Assured Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,386,808
Closed -$23.9M – 627
2017
Q3 		$23.9M Sell
2,386,808
-113,192
-5% -$1.12M 0.49% 38
2017
Q2 		$24.6M Hold
2,500,000
– – 0.51% 39
2017
Q1 		$24.9M Buy
+2,500,000
New +$24.7M 0.5% 44

Other funds holding ORGO

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Assured Investment Management's ORGO Position: Q4 2017 in Review

Assured Investment Management sold out of Organogenesis Holdings (ORGO) in Q4 2017, closing a stake of 2,386,808 shares — an estimated $23.9M sold.

Assured Investment Management first reported a position in ORGO in Q1 2017 and held it in 3 quarters. The position peaked at $24.9M in Q1 2017. 27 funds tracked by Wall St. Rank hold ORGO as of Q4 2017.

  • Assured Investment Management reported no remaining Organogenesis Holdings position as of Q4 2017 after selling out during the quarter.
  • Assured Investment Management sold 2,386,808 Organogenesis Holdings shares in Q4 2017, an estimated $23.9M.
  • Assured Investment Management first reported a position in Organogenesis Holdings in Q1 2017 and held it in 3 quarters.
  • Assured Investment Management's Organogenesis Holdings position peaked at $24.9M in Q1 2017.
  • 27 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2017.

Based on Assured Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.